Scarica l'app Stockscreener
22.19
1.68%
-0.38
Pre-mercato:
22.28
0.09
+0.41%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$22.57
Aprire:
$22.5
Volume 24 ore:
699.89K
Relative Volume:
1.24
Capitalizzazione di mercato:
$1.08B
Reddito:
$441.33M
Utile/perdita netta:
$9.76M
Rapporto P/E:
111.06
EPS:
0.1998
Flusso di cassa netto:
$839.00K
1 W Prestazione:
-1.20%
1M Prestazione:
-35.94%
6M Prestazione:
-52.44%
1 anno Prestazione:
-25.31%
Intervallo 1D:
$22.16
$23.11
Intervallo di 1 settimana:
$22.13
$23.60
Portata 52W:
$19.16
$48.25
Artivion Inc Stock (AORT) Company Profile
Nome
Artivion Inc
Settore
Industria
Telefono
(770) 419-3355
Indirizzo
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
22.19 | 1.10B | 441.33M | 9.76M | 839.00K | 0.1998 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-10 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2025-08-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | Iniziato | Canaccord Genuity | Buy |
| 2024-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-27 | Reiterato | Lake Street | Buy |
| 2022-08-08 | Iniziato | Lake Street | Buy |
| 2022-03-03 | Iniziato | Stifel | Buy |
Mostra tutto
Artivion Inc Borsa (AORT) Ultime notizie
AORT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition - MSN
Artivion secures FDA approval for NEXUS aortic arch system - MSN
Artivion (AORT) Earnings Date and Reports 2026 $AORT - MarketBeat
Artivion (AORT) Stock Forum and Discussion - Moomoo
Artivion Q1 earnings call highlights - MSN
AORT News | ARTIVION INC (NYSE:AORT) - ChartMill
Artivion (AORT) Q1 earnings and revenues surpass estimates - MSN
Artivion (AORT) director corrects details of restricted stock award - Stock Titan
Artivion (AORT) director receives 7,576-share equity award grant - Stock Titan
Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System - MedTech Intelligence
Artivion (NYSE:AORT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of - Yahoo Finance
Artivion (AORT) director receives 7,576-share equity RSA grant - Stock Titan
Artivion (AORT) director receives 7,850-share stock award, now holds 56,938 - Stock Titan
Artivion Earnings Call Balances Growth With Caution - TipRanks
Artivion closes Endospan buyout to acquire recently approved heart device - MedTech Dive
Artivion Bets On Full Aortic Arch Suite After Endospan Deal - Yahoo Finance
Artivion strengthens aortic arch portfolio with $135m Endospan acquisition - MSN
Artivion (AORT) Completes Acquisition of Endospan for Aortic Sol - GuruFocus
Artivion Closes $175 Million Acquisition of Endospan - Moomoo
Artivion Completes Acquisition of Endospan, Secures FDA Approval for NEXUS Aortic Arch System - Minichart
Artivion Closes $175M Deal for Aortic Arch Maker Endospan - Medical Product Outsourcing
Artivion completes $175M acquisition of Endospan - Investing.com UK
Artivion completes $175M acquisition of Endospan By Investing.com - Investing.com South Africa
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System - BioSpace
Artivion Closes Endospan Acquisition Following FDA Approval of NEXUS Aortic System - citybiz
Artivion completes $135 million Endospan acquisition - Investing.com
Artivion completes $135 million Endospan acquisition By Investing.com - Investing.com Australia
Artivion Completes Strategic Acquisition of Endospan Platform - TipRanks
Artivion completes acquisition of Endospan; $131.3M net upfront, up to $200M contingent - TradingView
Endospan acquisition gives Artivion (NYSE: AORT) FDA-approved NEXUS aortic arch system - Stock Titan
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS - Business Wire
Aortic surgery firm Artivion buys Endospan, NEXUS arch stent maker - Stock Titan
Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding - The Motley Fool
Artivion Q1 2026 Earnings: Revenue Matches Estimates, EPS Misses by 35%News and Statistics - IndexBox
5 Insightful Analyst Questions From Artivion’s Q1 Earnings Call - Yahoo Finance
Artivion, Inc. (NYSE:AORT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Artivion, Inc. completed the acquisition of Endospan Ltd. - marketscreener.com
Artivion shareholders elect directors and approve executive compensation By Investing.com - Investing.com Nigeria
Artivion shareholders elect directors and approve executive compensation - Investing.com
Artivion Shareholders Back Board, Pay and Auditor Choices - TipRanks
Artivion (AORT) shareholders approve directors, executive pay and Ernst & Young for 2026 - Stock Titan
Artivion Inc Azioni (AORT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):